Espanol AJ, Salem A, Di Bari M, Cristofaro I, et al. The metronomic combination of paclitaxel with cholinergic agonists inhibits triple negative breast tumor progression. Participation of M2 receptor subtype. PLoS One 2020;15:e0226450.
PMID: 32911509